Provided by Tiger Trade Technology Pte. Ltd.

HORIZON KINETICS MEDICAL ETF

34.96
-0.1032-0.29%
Post-market: 35.000.0428+0.12%16:10 EDT
Volume:2K
Turnover:66.28K
Market Cap:16.43M
PE:- -
High:35.10
Open:35.10
Low:34.96
Close:35.06
52wk High:37.90
52wk Low:28.87
Shares:469.95K
Float Shares:469.95K
Volume Ratio:0.73
T/O Rate:0.40%
Dividend:0.41
Dividend Rate:1.17%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Lilly is Bigger than Ever. Why Its Latest $2.9 Billion Immunology Deal Makes Sense.

Dow Jones
·
Aug 31

AbbVie to Present at Wells Fargo Healthcare Conference

Reuters
·
Aug 31

Eli Lilly's Psoriasis Drug Trial Shows Sustained Positive Results

Dow Jones
·
Aug 31

Lilly to Buy This Autoimmune Drugmaker for $2.9 Billion in Cash. What it Means for the Stock.

Dow Jones
·
Aug 31

Eli Lilly announces 52-week results from TOGETHER-PsO, TOGETHER-PsA

TIPRANKS
·
Aug 31

Eli Lilly - Taltz and Zepbound Lead to Deeper Improvements in Systemic Inflammation in Both Trials

THOMSON REUTERS
·
Aug 31

New Phase 3B Data on Lilly's Taltz (Ixekizumab) and Zepbound (Tirzepatide) Used Together Showed Improved and Durable Efficacy at One Year in Adults with Psoriatic Disease and Obesity

THOMSON REUTERS
·
Aug 31

Eli Lilly - Taltz and Zepbound Maintain or Improve Disease Activity at Week 52 Versus Taltz Alone

THOMSON REUTERS
·
Aug 31

Eli Lilly: Adverse Events in Participants Treated with Taltz and Zepbound Together were Generally Mild to Moderate

THOMSON REUTERS
·
Aug 31

Lilly to Acquire Merida Biosciences in Deal Worth up to USD 2.88 Billion

Reuters
·
Aug 31

Eli Lilly: Under Terms of Agreement, Lilly Will Acquire Merida and Pay up to $2.875 Bln in Cash

THOMSON REUTERS
·
Aug 31

Lilly to Acquire Merida Biosciences to Advance Treatments for Serious Autoimmune and Allergic Diseases

THOMSON REUTERS
·
Aug 31

Eli Lilly - Deal Expected to Close in Q4 2026 Subject to Regulatory Approvals

THOMSON REUTERS
·
Aug 31

Guangdong Hybribio Biotech's Subsidiary Secures In Vitro Diagnostic Device Registration Certificate

Stock News
·
Aug 31

Fed's Hawkish Signal Hits Hong Kong Drug Stocks: Innovative Medicine ETFs Slide Sharply

Deep News
·
Aug 31

Healthcare Sector Sees Continued Positive Signals; CCB Fund Manager Liang Furui Highlights High-Prosperity Areas Such as Innovative Drugs

Deep News
·
Aug 31

Three New Stock Subscriptions This Week, with One of China's "Four GPU Dragons" Opening for Subscription on Wednesday

Deep News
·
Aug 31

Tenax Therapeutics announces results from Phase 3 LEVEL trial of TNX-103

TIPRANKS
·
Aug 31

Three New Share Subscriptions Next Week Spanning AI Chip and Innovative Drug Hotspots; Nine IPOs This Year Have Already Delivered Over 100,000 Yuan Profit Per Lot

Deep News
·
Aug 30